Index by category›
Cosmetic & Aesthetic
27 entries. 22 await independent review.
Adifyline
Catalog coverage — independent review pendingAcetyl Hexapeptide-38
Adifyline is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
AHK-Cu
Preclinical research compound; no FDA or centrally authorised EU medicine identifiedL-alanyl-L-histidyl-L-lysine-Cu2+, (alanyl-histidyl-lysine)copper(II), AHK copper complex
AHK-Cu is the copper(II) complex of the synthetic tripeptide Ala-His-Lys. Its direct evidence consists mainly of one 2007 human-scalp hair-follicle study conducted ex vivo and in cultured dermal-papilla cells; no clinical AHK-Cu treatment trial or human pharmacokinetic study was located.
Argireline
Catalog coverage — independent review pendingAcetyl Hexapeptide-3
Argireline is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Capixyl
Catalog coverage — independent review pendingAcetyl Tetrapeptide-3 + Red Clover
Capixyl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Decorinyl
Catalog coverage — independent review pendingDecorin Analog
Decorinyl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Delisens
Catalog coverage — independent review pendingAcetyl Hexapeptide-46
Delisens is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Dermaxyl
Catalog coverage — independent review pendingC12-15 Alkyl Benzoate + Palmitoyl Hexapeptide-12
Dermaxyl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Diffuporine
Catalog coverage — independent review pendingAcetyl Hexapeptide-37
Diffuporine is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Eyeseryl
Catalog coverage — independent review pendingAcetyl Tetrapeptide-5
Eyeseryl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
GHK-Cu
Cosmetic ingredient (topical); injectable use is research-only and not approvedCopper tripeptide-1, GHK-copper, Glycyl-L-histidyl-L-lysine copper, Copper peptide
GHK-Cu is the copper(II) complex of the naturally occurring human tripeptide glycyl-L-histidyl-L-lysine (GHK). Plasma GHK declines with age, and the complex has well-documented roles in wound healing, collagen and extracellular-matrix synthesis, antioxidant defense, and broad gene-expression modulation. It is widely used and regarded as safe as a topical cosmetic ingredient, with some supportive human skin studies; injectable "research" use has no human trial evidence.
Juveleven
Catalog coverage — independent review pendingAcetyl Hexapeptide-51 Amide
Juveleven is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Lash Peptide
Catalog coverage — independent review pendingMyristoyl Pentapeptide-17
Lash Peptide is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Leuphasyl
Catalog coverage — independent review pendingPentapeptide-18
Leuphasyl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Matrixyl
Catalog coverage — independent review pendingPalmitoyl Pentapeptide-4
Matrixyl is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Matrixyl 3000
Catalog coverage — independent review pendingPalmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7
Matrixyl 3000 is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Matrixyl Synthe'6
Catalog coverage — independent review pendingPalmitoyl Tripeptide-38
Matrixyl Synthe'6 is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Melanotan I
Approved medicine (EMA 2014, FDA 2019) for EPP onlyAfamelanotide, Scenesse (brand), Melanotan 1, [Nle4-D-Phe7]-alpha-MSH, NDP-MSH, NDP-alpha-MSH, CUV1647
A synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) and melanocortin-1 receptor agonist, marketed as Scenesse and approved by the EMA (2014) and FDA (2019) to prevent phototoxicity in adults with erythropoietic protoporphyria (EPP), a rare painful light-sensitivity disorder, not for cosmetic tanning.
Melanotan II
Research chemical (not approved; subject to regulator warnings)Melanotan 2, MT-II, MT-2
A synthetic cyclic heptapeptide and non-selective melanocortin receptor agonist (MC1R/MC3R/MC4R/MC5R) studied in small human trials for skin tanning and erectile function. It is not approved as a medicine anywhere, is widely sold as an unregulated injectable, and is associated with documented serious harms including priapism, nausea, changes in moles, and rare reports of rhabdomyolysis and encephalopathy. It is distinct from the approved drug afamelanotide (Melanotan I / Scenesse).
Melitane
Catalog coverage — independent review pendingAcetyl Hexapeptide-1
Melitane is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Progeline
Catalog coverage — independent review pendingF3acetyl Tripeptide-2
Progeline is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
PTD-DBM
Catalog coverage — independent review pendingProtein Transduction Domain-DBM
PTD-DBM is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Rigin
Catalog coverage — independent review pendingPalmitoyl Tetrapeptide-7
Rigin is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
SNAP-8 (Acetyl Octapeptide-3)
Cosmetic ingredient (topical) / research reagent; not an approved drugAcetyl Octapeptide-3, Acetyl glutamyl heptapeptide-1, Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2, Acetyl-EEMQRRAD-amide, SNAP-8 (trademark)
SNAP-8 (INCI Acetyl Octapeptide-3) is a synthetic, acetylated and amidated octapeptide marketed as a topical cosmetic "neuromodulating" ingredient and sold as a research reagent. Its identity and sequence are well documented, but its anti-wrinkle efficacy claims come from manufacturer literature rather than independent trials. Not an approved drug.
Syn-Ake
Catalog coverage — independent review pendingDipeptide Diaminobutyroyl Benzylamide
Syn-Ake is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Syn-Coll
Catalog coverage — independent review pendingPalmitoyl Tripeptide-5
Syn-Coll is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Telangyn
Catalog coverage — independent review pendingAcetyl Tetrapeptide-40
Telangyn is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Uplevity
Catalog coverage — independent review pendingAcetyl Tetrapeptide-2
Uplevity is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.